Bimeda is a global manufacturer, marketer and distributor of veterinary pharmaceuticals and animal health products. Bimeda Limited (Kenya) is part of the wider Bimeda AMEA business unit, which has a strong presence across the Africa, Asia and Middle East regions. Bimeda Limited is one of the largest veterinary pharmaceutical manufacturers and distributors in Eastern and Central Africa.
The Kenyan business headquarters is situated in Nairobi, where the sales, marketing, HR, finance and logistics functions are based. In addition to being the headquarter, Nairobi is home to the distribution facility, from which products are supplied to the entire Central and East African region.
Bimeda has broad product range with products licensed for species including cattle, sheep, pigs, poultry, camels, goats, horses and dogs. Their portfolio includes a wide array of product categories, such as acaricides, anthelmintics, antimicrobials, vaccines, hormones, nutritional products, bull semen, anti-inflammatories, anti-East Coast Fever injections and more.
Bimeda is committed to being the leading distributor or quality and cost-effective animal health products, which meet the needs of customers in maintaining the good health and productivity of their livestock.
BIMEDA ACQUIRES AQUATACTICS FISH HEALTH
May 2021: Bimeda acquires AquaTactics Fish Health (“AquaTactics”), based in Seattle, Washington. The company provides fish health services and develops, manufactures and sells bespoke fish vaccines to its fish farm and stock enhancement clients across the USA.
This is Bimeda’s first investment in the Aquaculture space and is a strategic investment in a rapidly growing animal healthcare segment. This marks Bimeda’s second preventative health acquisition in 18 months, following on from the purchase of Texas Vet Lab (now Bimeda Biologicals) in December 2019, and signals the company’s strategic interest in the preventative health sector.